US2015191767A1PendingUtilityA1
Structure-activity relationships
Est. expiryFeb 12, 2027(~0.6 yrs left)· nominal 20-yr term from priority
Inventors:Emily MundorffSimon Christopher DavisGjalt W. HuismanAnke KrebberJohn H. GrateRichard J. Fox
C12Q 1/25G16B 20/30G16B 20/50G01N 33/6845C12N 15/1093C12N 9/00C40B 40/10C40B 40/02G01N 33/6803G16B 20/00C12Q 1/00C40B 10/00C40B 30/04C12Q 1/26
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to compositions and methods for screening a plurality of polypeptide variants.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A kit for identifying at least one polypeptide having a desired activity for a ligand of interest, containing:
(i) at least one plurality of active addressable polypeptide variants, wherein each member of each plurality of the active polypeptide variants reacts with at least one ligand to produce a detectable signal, and wherein at least two members of each plurality of the active polypeptide variants are related to a parent polypeptide and react with different ligands, wherein the different ligand does not react with the parent polypeptide; (ii) at least one ligand, wherein said ligand is placed within the wells of a microtiter plate;
and
(iii) instructions for use.
2 . The kit of claim 1 , wherein said at least one ligand is immobilized in the wells of said microtiter plate.
3 . The kit of claim 1 , wherein each of the wells of said microtiter plate contain different ligands.
4 . A kit for identifying at least one polypeptide having a desired activity for a ligand of interest, containing:
(i) at least one plurality of active addressable polypeptide variants, wherein each member of each plurality of the active polypeptide variants reacts with at least one ligand to produce a detectable signal, and wherein at least two members of each plurality of the active polypeptide variants are related to a parent polypeptide and react with different ligands, wherein the different ligand does not react with the parent polypeptide wherein each member of said plurality of active polypeptide variants is placed within a well of a microtiter plate; (ii) at least one ligand; and (iii) instructions for use.
5 . The kit of claim 4 , wherein each member of said plurality of polypeptide variants is immobilized in the wells of said microtiter plate.
6 . The kit of claim 4 , wherein at least two members of each plurality of active addressable polypeptide variants are related to a parent polypeptide and react with differing levels of activity upon said at least one ligand.
7 . The kit of claim 4 , further comprising at least one means of generating a signal.
8 . The kit of claim 8 , further comprising at least one means of detecting said signal.
9 . The kit of claim 1 , wherein the plurality of active addressable polypeptide variants are operable under conditions in which the parent polypeptide is inactive or rendered inactive.
10 . The kit of claim 4 , wherein the plurality of active addressable polypeptide variants are operable under conditions in which the parent polypeptide is inactive or rendered inactive.
11 . The kit of claim 1 , wherein the plurality of active addressable polypeptide variants are enzymes, and the ligands correspond to substrates for the enzymes.
12 . The kit of claim 4 , wherein the plurality of active addressable polypeptide variants are enzymes, and the ligands correspond to substrates for the enzymes.
13 . The kit of claim 1 , wherein the parent polypeptide is a wild-type enzyme.
14 . The kit of claim 4 , wherein the parent polypeptide is a wild-type enzyme.
15 . A kit for identifying at least one polypeptide having a desired activity for a ligand of interest, containing:
(i) at least one plurality of active addressable polypeptide variants, wherein each member of the plurality of active addressable polypeptide variants reacts with at least one ligand of a plurality of ligands and at least two members of the plurality of the active addressable polypeptide variants are related to a parent polypeptide, wherein one member has been selected for improved activity for one ligand and the other member has been selected for improved activity for a different ligand in the plurality of ligands as compared to the parent polypeptide; (ii) a plurality of ligands; and (ii) instructions for use.Join the waitlist — get patent alerts
Track US2015191767A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.